OW26 documents - All Wales Therapeutics and Toxicology Centre

Print this page (expand headings to print hidden text)

09/10/2024
First review: dostarlimab (OW26) OWID

09/05/2024
Table 2: Estimated patient numbers and cost

09/05/2024
Table 1: Total costs of each treatment arm option per patient**

03/08/2023
Original assessment: Dostarlimab (OW26) Evidence Status Report Aug 2023

03/08/2023
Original assessment: Dostarlimab (OW26) One Wales Interim Decision with rationale Aug 23

	Title	Reference number	One Wales process status	Date of OWMAG meeting	Date of AWMSG meeting